FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224983059> ?p ?o ?g. }

• W4224983059 abstract "Abstract Background/purpose Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in the pediatric population and anterior uveitis is its commonest extra-articular manifestation. Typically the uveitis presents as chronic anterior uveitis and there is limited literature of the posterior segment manifestations of the disease. Similar to other vaccines, anti-SARS-CoV-2 vaccination that began as an urgent measure to control the spread of the SARS-CoV-2 pandemic has not been without adverse events. We are reporting a 19-year-old Asian Indian female who was diagnosed and treated for JIA associated anterior uveitis that was unilateral and was under anti-inflammatory control but showed worsening of uveitis with posterior segment inflammation in both eyes following anti-SARS-CoV-2 vaccination. Case report A 19-year-old Asian Indian female with a history of juvenile idiopathic arthritis on treatment with methotrexate, presented with right eye chronic anterior uveitis with peripheral subclinical retinal vasculitis and macular edema which was brought under control following administration of adalimumab. She was inflammation free for 6 months until she received anti-SARS-CoV-2 vaccination and developed new onset floaters in both eyes that were initially noted after the first dose and increased after the second dose. Clinical examination revealed presence of keratic precipitates and grade 1+ anterior chamber inflammation along with vitiritis in both eyes. Fundus fluorescein angiography revealed angiographically active retinal vasculitis without the presence of macular edema in both eyes. This was managed with a short course of topical difluprednate and continuation of systemic immunosuppressive therapy with adalimumab and methotrexate. Conclusion JIA associated uveitis results from an autoimmune process which can be controlled with timely immunosuppressive treatment. It is important to be aware of the potential risk of flare up of uveitis with posterior segment manifestations following anti- SARS-CoV-2 vaccination." @default.
• W4224983059 created "2022-04-28" @default.
• W4224983059 creator A5008562162 @default.
• W4224983059 creator A5017452297 @default.
• W4224983059 creator A5028881357 @default.
• W4224983059 creator A5048317297 @default.
• W4224983059 creator A5071720088 @default.
• W4224983059 creator A5087862400 @default.
• W4224983059 creator A5089397394 @default.
• W4224983059 date "2022-04-27" @default.
• W4224983059 modified "2023-09-25" @default.
• W4224983059 title "Reactivation of juvenile idiopathic arthritis associated uveitis with posterior segment manifestations following anti-SARS-CoV-2 vaccination" @default.
• W4224983059 cites W2008582802 @default.
• W4224983059 cites W2036442655 @default.
• W4224983059 cites W2062170681 @default.
• W4224983059 cites W2064325706 @default.
• W4224983059 cites W2076669162 @default.
• W4224983059 cites W2098254193 @default.
• W4224983059 cites W2114386527 @default.
• W4224983059 cites W2339312188 @default.
• W4224983059 cites W2344163114 @default.
• W4224983059 cites W2566291794 @default.
• W4224983059 cites W2571296589 @default.
• W4224983059 cites W2791846933 @default.
• W4224983059 cites W2792992921 @default.
• W4224983059 cites W2897201139 @default.
• W4224983059 cites W2898066283 @default.
• W4224983059 cites W2936070658 @default.
• W4224983059 cites W2955068995 @default.
• W4224983059 cites W3107056629 @default.
• W4224983059 cites W3135094834 @default.
• W4224983059 cites W3159148372 @default.
• W4224983059 cites W3167698984 @default.
• W4224983059 cites W3180751199 @default.
• W4224983059 cites W3190245747 @default.
• W4224983059 cites W3198258149 @default.
• W4224983059 cites W3199520026 @default.
• W4224983059 cites W3200090586 @default.
• W4224983059 cites W3200599893 @default.
• W4224983059 cites W4200406851 @default.
• W4224983059 cites W4206095065 @default.
• W4224983059 cites W4206533230 @default.
• W4224983059 cites W4213274805 @default.
• W4224983059 cites W98043794 @default.
• W4224983059 doi "https://doi.org/10.1186/s12348-022-00294-2" @default.
• W4224983059 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35476156" @default.
• W4224983059 hasPublicationYear "2022" @default.
• W4224983059 type Work @default.
• W4224983059 citedByCount "5" @default.
• W4224983059 countsByYear W42249830592022 @default.
• W4224983059 crossrefType "journal-article" @default.
• W4224983059 hasAuthorship W4224983059A5008562162 @default.
• W4224983059 hasAuthorship W4224983059A5017452297 @default.
• W4224983059 hasAuthorship W4224983059A5028881357 @default.
• W4224983059 hasAuthorship W4224983059A5048317297 @default.
• W4224983059 hasAuthorship W4224983059A5071720088 @default.
• W4224983059 hasAuthorship W4224983059A5087862400 @default.
• W4224983059 hasAuthorship W4224983059A5089397394 @default.
• W4224983059 hasBestOaLocation W42249830591 @default.
• W4224983059 hasConcept C113520495 @default.
• W4224983059 hasConcept C118487528 @default.
• W4224983059 hasConcept C126322002 @default.
• W4224983059 hasConcept C141071460 @default.
• W4224983059 hasConcept C197934379 @default.
• W4224983059 hasConcept C2776015282 @default.
• W4224983059 hasConcept C2776194053 @default.
• W4224983059 hasConcept C2776391266 @default.
• W4224983059 hasConcept C2777077863 @default.
• W4224983059 hasConcept C2777138892 @default.
• W4224983059 hasConcept C2777575956 @default.
• W4224983059 hasConcept C2778328719 @default.
• W4224983059 hasConcept C2779134260 @default.
• W4224983059 hasConcept C2780132546 @default.
• W4224983059 hasConcept C2780347916 @default.
• W4224983059 hasConcept C2780827179 @default.
• W4224983059 hasConcept C71924100 @default.
• W4224983059 hasConceptScore W4224983059C113520495 @default.
• W4224983059 hasConceptScore W4224983059C118487528 @default.
• W4224983059 hasConceptScore W4224983059C126322002 @default.
• W4224983059 hasConceptScore W4224983059C141071460 @default.
• W4224983059 hasConceptScore W4224983059C197934379 @default.
• W4224983059 hasConceptScore W4224983059C2776015282 @default.
• W4224983059 hasConceptScore W4224983059C2776194053 @default.
• W4224983059 hasConceptScore W4224983059C2776391266 @default.
• W4224983059 hasConceptScore W4224983059C2777077863 @default.
• W4224983059 hasConceptScore W4224983059C2777138892 @default.
• W4224983059 hasConceptScore W4224983059C2777575956 @default.
• W4224983059 hasConceptScore W4224983059C2778328719 @default.
• W4224983059 hasConceptScore W4224983059C2779134260 @default.
• W4224983059 hasConceptScore W4224983059C2780132546 @default.
• W4224983059 hasConceptScore W4224983059C2780347916 @default.
• W4224983059 hasConceptScore W4224983059C2780827179 @default.
• W4224983059 hasConceptScore W4224983059C71924100 @default.
• W4224983059 hasIssue "1" @default.
• W4224983059 hasLocation W42249830591 @default.
• W4224983059 hasLocation W42249830592 @default.
• W4224983059 hasLocation W42249830593 @default.
• W4224983059 hasOpenAccess W4224983059 @default.
• W4224983059 hasPrimaryLocation W42249830591 @default.
• W4224983059 hasRelatedWork W1756079539 @default.

• next